Cargando…
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
BACKGROUND: Large vessel vasculitis (LVV) is a type of vasculitis characterized by granulomatous inflammation of medium- and large-sized arteries. Clinical assessment of acute phase reactants has been conventionally used to diagnose and monitor diseases; however, accurate assessment of vascular dise...
Autores principales: | Matsumoto, Kotaro, Suzuki, Katsuya, Yoshimoto, Keiko, Seki, Noriyasu, Tsujimoto, Hideto, Chiba, Kenji, Takeuchi, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937853/ https://www.ncbi.nlm.nih.gov/pubmed/31888748 http://dx.doi.org/10.1186/s13075-019-2068-7 |
Ejemplares similares
-
Longitudinal immune cell monitoring identified CD14(++) CD16(+) intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2020) -
Interleukin‐1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysis
por: Matsumoto, Kotaro, et al.
Publicado: (2021) -
Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2021) -
Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses
por: Matsumoto, Kotaro, et al.
Publicado: (2021) -
Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors
por: Matsumoto, Kotaro, et al.
Publicado: (2023)